| NCT ID | NCT04291651 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Pancreatic Cyst |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2019-10-08 |
| Primary Completion | 2030-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 2019-10-08 with a primary completion date of 2030-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Pancreatic cysts are found incidentally on 15-50% of CT and MRIs for all indications and their prevalence is increasing. Many of these cysts may be precursors to pancreatic cancer, and thus pose a substantial risk, however, the vast majority are benign. Increased detection of pancreatic cysts provides an opportunity to diagnose pancreatic malignancy at an early, curable stage yet also increases the potential to over-treat clinically insignificant lesions. This presents a clinical challenge to prevent unnecessary resection of indolent disease, with associated risks of infections, bleeding, diabetes, and costly disability. Unfortunately, there is little information on the epidemiology and natural history of pancreatic cysts to help guide management.
Eligibility Criteria
Inclusion Criteria: * The inclusion criteria for this study are intentionally broad. Eligible patients for prospective enrollment will include * Adults ≥ 30 years of age * Have a radiographic or endoscopic diagnosis of at least one pancreatic cysts regardless of treatment status, * No history of pancreatic cancer, * Can speak and read English, * Have access to a computer or mobile device (\~95% of U.S. population); and * Are able to complete an electronic informed consent. Exclusion Criteria: * Patients who don't speak English, * Don't have access to a computer or mobile device; or * Patients who have a cancer diagnosis.
Contact & Investigator
Kimberly S Kirkwood, MD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT04291651 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreatic Cyst. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04291651 currently recruiting?
Yes, NCT04291651 is actively recruiting participants. Contact the research team at Charysa.Santos@ucsf.edu for enrollment information.
Where is the NCT04291651 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT04291651 clinical trial?
NCT04291651 is sponsored by University of California, San Francisco. The principal investigator is Kimberly S Kirkwood, MD at University of California, San Francisco. The trial plans to enroll 4,000 participants.